Teva Pharmaceutical Industries Ltd. has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive...
Read More
Loss-affected lines of business, such as property catastrophe in Europe, cyber or retrocession, continued to see significant price increases during...
Read More